The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Abbott announced FDA approval for its new blood and plasma screening Alinity™ s System.
read more
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
read more
Schrödinger announced an expansion of its design collaboration with Morphic, a biotechnology company developing a class of oral small-molecule ...
read more
Gedeon Richter has launched its biosimilar teriparatide, Terrosa® in Europe. The product is approved in adults for the same indications as Eli Lilly’s...
read more
BiomX announced completion a new manufacturing facility.
read more
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat ...
read more
The FDA has awarded 12 new clinical trial research grants totaling more than $15 million over the next four years to enhance the development of ...
read more
Friday, November 08, 2019
SQZ Biotechnologies and AskBio announced a research collaboration to create TACs containing AAV components to solve the barrier to treatment posed by ...
read more
Thursday, January 09, 2020
Aruvant announced the FDA has granted Rare Pediatric Disease designation to ARU-1801, an investigational therapy for sickle cell disease.
read more
Tuesday, January 14, 2020
Advanced BioMatrix has acquired the HyStem® line of products from Lineage Cell Therapeutics – previously BioTime/ESI Bio/Glycosan.
read more
Wednesday, January 22, 2020
Algentech has announced the issuance of a key patent in the field of genome editing by the U.S. Patent Office (U.S. patent number 10457950).
read more
Tuesday, February 11, 2020
Alkahest announced the initiation of a phase 2b clinical trial of its orally administered small molecule CCR3 inhibitor, AKST4290.
read more
Wednesday, February 19, 2020
The FDA plays an essential role in overseeing our Nation’s medical products as part of our vital mission to protect and promote public health, ...
read more
Wednesday, February 26, 2020
CPhI Japan has announced the event will be postponed until a new date later in the year after consultation with key stakeholders and consideration of ...
read more
F2G announced the FDA has granted ODD to its lead first-in-class candidate, olorofim for invasive aspergillosis and for treatment of lomentospora/...
read more